Balancing the risks and benefits of drinking water disinfection: Disability adjusted life-years on the scale

Environmental Health Perspectives

Volumn 108, Issue 4, 2000, Pages 315-321

  Havelaar, Arie H ^a   De Hollander, Augustinus E M ^a   Teunis, Peter F M ^a   Evers, Eric G ^a   Van Kranen, Henk J ^a   Versteegh, Johanna F M ^a   Van Koten, Joke E M ^a   Slob, Wout ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Bromate; Cryptosporidium parvum; Disinfection; Drinking water; Ozone; Quality of life; Risk Assessment

Indexed keywords

BROMATE; DRINKING WATER; OZONE; SURFACE WATER;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CANCER MORTALITY; CANCER RISK; CRYPTOSPORIDIUM PARVUM; DEATH; DISABILITY; DISINFECTION; GASTROENTERITIS; HUMAN; INFECTION RISK; KIDNEY CARCINOMA; MEASUREMENT; MORBIDITY; NETHERLANDS; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; WATER CONTAMINATION; WATER TREATMENT;

EID: 0034102597     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.00108315     Document Type: Article

References (42)

1. WHO. Guidelines for Drinking-Water Quality. 2nd ed. Vol. 2: Health Criteria and Other Supporting Information. Geneva: World Health Organization, 1996.
2. Craun GF, Bull RJ, Clark RM, Doull J, Grabow W, Marsh GM, Okun DA, Regli, S, Sobsey MD, Symons JM. Balancing chemical and microbiological risks of drinking water disinfection. Part I: benefits and potential risks. Aqua (Oxf) 43:192-199 (1994).
3. National Academy of Sciences, National Research Council. Risk Assessment in the Federal Government: Managing the Process. Washington, DC:National Academy Press, 1983.
4. Colford JM, Tager IB, Hirozawa AM, Lemp, GF, Aragon T, Petersen C. Cryptosporidiosis among patients infected with human immunodeficiency virus. Am J Epidemiol 144:807-816 (1996).
5. Richardson AJ, Frankenberg RA, Buck AC, Selkon JB, Colbourne JS, Parsons JW, Mayon-White RT. An outbreak of waterborne cryptosporidiosis in Swindon and Oxfordshire. Epidemiol Infect 107:485-495 (1991).
6. Mac Kenzie WR, Hoxie NJ, Proctor ME, Gradus MS, Blair KA, Peterson DE, Kazmierczak JJ, Addiss DG, Fox KR, Rose JB, et al. A massive outbreak in Milwaukee of Cryptosporidium infection transmitted through the public water supply. N Engl J Med 331:161-167 (1994).
7. Ozekin K, Westerhoff P. Bromate formation under Cryptosporidium inactivation conditions. Water Qual Int May/June:16-17 (1998).
8. Kurokawa Y, Maekawa A, Takahashi M, Hayashi Y. Toxicity and carcinogenicity of potassium bromate - 3 new renal carcinogen. Environ Health Perspect 87:309-335 (1990).
9. DeAngelo AB, George MH, Kilburn SR, Moore TM, Wolf DC. Carcinogenicity of potassium bromate administered in the drinking water to male B6C3F, mice and F344/N rats. Toxicol Pathol 26:587-594 (1998).
10. Weinberg HS, Glaze WH. An overview of ozonation disinfection by-products. In: Disinfection By-Products in Water Treatment: The Chemistry of Their Formation and Control (Minear RA, Amy GL, eds). Boca Raton, FL:Lewis Publishers, 1996;165-186.
11. Marinas BJ, Rennecker JL, Teefy S, Rice EW. Assessing ozone disinfection with non biological surrogates. J Am Water Works Assoc 91:79-89 (1999).
12. Teunis PFM, Medema GJ, Kruidenier L, Havelaar AH. Assessment of the risk of infection by Cryptosporidium or Giardia in drinking water from a surface water source. Water Res 31:1333-1346 (1997).
13. Havelaar AH, Van Olphen M, Schijven JF. Removal and inactivation of viruses by drinking water treatment processes under full scale conditions. Water Sci Technol 31:55-62 (1995).
14. Van der Veer B, Schers G-J, Wilkes DR. Optimization of an ozonation system design to achieve disinfection and oxidation. In: Proceedings of the AWWA Annual Conference, Engineering and Operations, 19-23 June 1994, New York Denver, CO:American Water Works Association, 1994;799-821.
15. Vose D. Quantitative risk analysis. A guide to Monte Carlo simulation modelling. Chichester:John Wiley & Sons Ltd, 1996.
16. Haas CN, Joffe J, Heath MS, Jacangelo J. Continuous flow residence time distribution function characterization. J Environ Eng 123:107-114 (1997).
17. Finch GR, Black EK, Gyürék L, Belosevic M. Ozone inactivation of Cryptosporidium parvum in demand-free phosphate buffer determined by in vitro excystation and animal infectivity. Appl Environ Microbiol 59:4203-4210 (1993).
18. Versteegh JFM, Neele J, Cleven RFMJ, Van Gaalen FW. Bromaat Tijdens de Drinkwaterzuivering en in Drinkwater [in Dutch]. Rapport no. 734301007. Bilthoven:Rijksinstituut voor Volksgezondheid en Milieu, 1995.
19. Song R, Donohoe C, Minear R, Westerhoff P, Ozekin K, Amy G. Empirical modeling of bromate formation during ozonation of bromide-containing waters. Water Res 30:1161-1168 (1996).
20. Haring BJA, Karres JJC, Van der Poel P, Zoeteman BCJ. Onderzoek Naar de Gebruiksgewoonten bij Drinkwater-consumptie in Nederland [in Dutch]. H 2 O 12:212-216 (1979).
21. Haas CN. Estimation of risk due to low doses of microorganisms: a comparison of alternative methodologies. Am J Epidemiol 118:573-582 (1983).
22. Teunis PFM, Van der Heijden OG, Van der Giessen JWB, Havelaar AH. The Dose-Response Relation in Human Volunteers for Gastro-Intestinal Pathogens. Report no. 284550002. Bilthoven:National Institute of Public Health and the Environment, 1996.
23. DuPont HL, Chappel CL, Sterling CR, Okhuysen PC, Rose JB, Jakubowski W. The infectivity of Cryptosporidium in healthy volunteers. N Engl J Med 332:855-859 (1995).
24. Kurokawa Y, Takayama S, Konishi Y, Hiasa Y, Asahina S, Takahashi M, Maekawa A, Hayashi Y. Long-term in vivo carcinogenicity tests of potassium bromate, sodium hypochlorite, and sodium chlorite conducted in Japan. Environ Health Perspect 69:221-235 (1986).
25. U.S. Environmental Protection Agency. Guidelines for cancer risk assessment. Fed Reg 51:33992-34003 (1986).
26. U.S. Environmental Protection Agency. Proposed guidelines for cancer risk assessment. Fed Reg 61:17959-18011 (1996).
27. Kurokawa Y, Hayashi Y, Maekawa A, Takahashi M, Kokubo T, Odashima S. Carcinogenicity of potassium bromate administered orally to F344 rats. J Natl Cancer Inst 71:965-972 (1983).
28. Slob W, Pieters MN. A probabilistic approach for deriving acceptable human intake limits and human health risks from toxicological studies: general framework. Risk Anal 18:787-798 (1998).
29. Murray CJL. Rethinking DALYs. In: The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020 (Murray CJL, Lopez AD, eds). Global Burden of Disease and Injury Series, Vol 1. Boston, MA:Harvard School of Public Health on behalf of the World Health Organization and the World Bank, 1996;1-98.
30. Van der Maas PJ, Kramers PGN, eds. Gezondheid en Levensverwachting Gewogen. Volksgezondheid Toekomst Verkenning 1997, deel III [in Dutch] . Bilthoven/Maarssen:Rijksinstituut voor Volksgezondheid en Milieu/Elsevier/De Tijdstroom, 1997.
31. Ockhysen PC, Chappel CL, Sterling CR, Jakubowski W, DuPont H. Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum. Inf Immun 66:441-443 (1998).
32. Mac Kenzie WR, Kazmierczak JJ, Davis JP. An outbreak of cryptosporidiosis associated with a resort swimming pool. Epidemiol Infect 115:545-553 (1995).
33. Mac Kenzie WR, Schell WL, Blair KA, Addiss DG, Peterson DE, Hoxie NJ, Kazmierczak JJ, Davis JP. Massive outbreak of waterborne Cryptosporidium infection in Milwaukee, Wisconsin: recurrence of illness and risk of secondary transmission. Clin Infect Dis 21:57-62 (1995).
34. Nord E. The person-trade-off approach to valuing health care programmes. Med Decis Making 15:201-208 (1995).
35. Hoxie NJ, Davis JP, Vergeront JM. Cryptosporidiosis-associated mortality following a massive waterborne outbreak in Milwaukee, Wisconsin. Am J Publ Health 87:2032-2035 (1997).
36. CBS. Overledenen naar Doodsoorzaak (Serie A1), 1993-1995 [in Dutch]. Voorburg:Centraal Bureau voor de Statistiek, 1996.
37. Schouten LJ, Van den Brandt PA, Jager JJ, Smeets LBJM. Netherlands, Maastricht. IARC Sci Publ 120:670-672 (1992).
38. Perz JF, Ennever FK, Le Blanc SM. Cryptosporidium in tapwater. Comparison of predicted risks with observed levels of disease. Am J Epidemiol 147:289-301 (1998).
39. McGowan I, Hawkins AS, Weller IV. The natural history of cryptosporidial diarrhoea in HIV-infected patients. AIDS 7:349-354 (1993).
40. Houweling H. Public Health Surveillance of AIDS and HIV Infection in the Netherlands and Europe [PhD Thesis]. Amsterdam:University of Amsterdam, 1997.
41. Coebergh JWW, Damhuis RAM. Cancer of kidney and ureter. In: Cancer Incidence and Survival in the Southeast of the Netherlands, 1955-1994 (Coebergh JWW, Van der Heijden LH, Janssen-Heijnen MLG, eds). Eindhoven, The Netherlands:Comprehensive Cancer Centre South, 1995:74-75.
42. Damhuis RA, Blom JH. The influence of age on treatment choice and survival in 735 patients with renal carcinoma. Br J Urol 75:143-147 (1995).